Vournakis J - Search Results

1

A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agent.

Cole DJ, Connolly RJ, Chan MW, Schwaitzberg SD, Byrne TK, Adams DB, Baron PL, O'Brien PH, Metcalf JS, Demcheva M, Vournakis J. Cole DJ, et al. Among authors: vournakis j. Surgery. 1999 Sep;126(3):510-7. Surgery. 1999. PMID: 10486603

2

Comparison of poly-N-acetyl glucosamine (P-GlcNAc) with absorbable collagen (Actifoam), and fibrin sealant (Bolheal) for achieving hemostasis in a swine model of splenic hemorrhage.

Chan MW, Schwaitzberg SD, Demcheva M, Vournakis J, Finkielsztein S, Connolly RJ. Chan MW, et al. Among authors: vournakis j. J Trauma. 2000 Mar;48(3):454-7; discussion 457-8. doi: 10.1097/00005373-200003000-00013. J Trauma. 2000. PMID: 10744283

3

Arterial embolization using poly-N-acetyl glucosamine gel in a rat kidney model.

Kang QK, An YH, Moreira PL, Demcheva MV, Vournakis JN. Kang QK, et al. Anat Rec A Discov Mol Cell Evol Biol. 2005 May;284(1):454-9. doi: 10.1002/ar.a.20187. Anat Rec A Discov Mol Cell Evol Biol. 2005. PMID: 15803477 Free article.

4

Hemostatic properties of glucosamine-based materials.

Fischer TH, Bode AP, Demcheva M, Vournakis JN. Fischer TH, et al. J Biomed Mater Res A. 2007 Jan;80(1):167-74. doi: 10.1002/jbm.a.30877. J Biomed Mater Res A. 2007. PMID: 17001651

5

Poly-N-acetyl glucosamine fibers activate bone regeneration in a rabbit femur injury model.

Muise-Helmericks RC, Demcheva M, Vournakis JN, Seth A. Muise-Helmericks RC, et al. Among authors: vournakis jn. J Trauma. 2011 Aug;71(2 Suppl 1):S194-6. doi: 10.1097/TA.0b013e3182258799. J Trauma. 2011. PMID: 21814118

6

Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.

Maitre N, Brown JM, Demcheva M, Kelley JR, Lockett MA, Vournakis J, Cole DJ. Maitre N, et al. Among authors: vournakis j. Clin Cancer Res. 1999 May;5(5):1173-82. Clin Cancer Res. 1999. PMID: 10353754

7

Poly-N-acetyl glucosamine: will it replace cyanoacrylate for treatment of gastric varices? A pilot study in a rabbit model.

Kulling D, Woo S, Demcheva MV, Hawes RH, Vournakis JN. Kulling D, et al. Among authors: vournakis jn. Endoscopy. 1998 Mar;30(3):S41-2. doi: 10.1055/s-2007-1001271. Endoscopy. 1998. PMID: 9615894 No abstract available.

8

Endoscopic injection of bleeding esophageal varices with a poly-N-acetyl glucosamine gel formulation in the canine portal hypertension model.

Kulling D, Vournakis JN, Woo S, Demcheva MV, Tagge DU, Rios G, Finkielsztein S, Hawes RH. Kulling D, et al. Among authors: vournakis jn. Gastrointest Endosc. 1999 Jun;49(6):764-71. doi: 10.1016/s0016-5107(99)70298-1. Gastrointest Endosc. 1999. PMID: 10343225

9

Sustained release of granulocyte-macrophage colony-stimulating factor from a modular peptide-based cancer vaccine alters vaccine microenvironment and enhances the antigen-specific T-cell response.

Nguyen CL, Bui JT, Demcheva M, Vournakis JN, Cole DJ, Gillanders WE. Nguyen CL, et al. Among authors: vournakis jn. J Immunother. 2001 Sep-Oct;24(5):420-9. J Immunother. 2001. PMID: 11696697

10

Characterization of a sustained-release delivery system for combined cytokine/peptide vaccination using a poly-N-acetyl glucosamine-based polymer matrix.

Cole DJ, Gattoni-Celli S, McClay EF, Metcalf JS, Brown JM, Nabavi N, Newton DA 3rd, Woolhiser CB, Wilson MC, Vournakis JN. Cole DJ, et al. Among authors: vournakis jn. Clin Cancer Res. 1997 Jun;3(6):867-73. Clin Cancer Res. 1997. PMID: 9815761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters